ISIN | LU2796587793 |
---|---|
Valor Number | 134146113 |
Bloomberg Global ID | UBSGCKA LX |
Fund Name | UBS (Lux) Strategy Fund - Growth (CHF) K-1-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Global Aggressive |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The aim of the investment policy is to seek optimal capital growth in terms of the currency of account. To this end, investments are made worldwide on a broadly diversified basis, mainly in bonds and equities, with the majority of Fund assets generally invested in equities. Thus, the investment risk of this sub-fund is typically higher than that of the Balanced sub-funds. In line with this investment policy, the sub-funds may invest in high yield bonds, emerging market bonds and commodities. |
Peculiarities |
Current Price * | 5,400,346.84 CHF | 05.06.2025 |
---|---|---|
Previous Price * | 5,390,745.53 CHF | 04.06.2025 |
52 Week High * | 5,503,805.77 CHF | 18.02.2025 |
52 Week Low * | 4,782,825.34 CHF | 07.04.2025 |
NAV * | 5,400,346.84 CHF | 05.06.2025 |
Issue Price * | 5,400,346.84 CHF | 05.06.2025 |
Redemption Price * | 5,400,346.84 CHF | 05.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 628,926,122 | |
Unit/Share Assets *** | 4,614,969 | |
Trading Information SIX |
YTD Performance | +3.13% |
31.12.2024 - 05.06.2025
31.12.2024 05.06.2025 |
---|---|---|
1 month | +2.91% |
05.05.2025 - 05.06.2025
05.05.2025 05.06.2025 |
3 months | +0.05% |
05.03.2025 - 05.06.2025
05.03.2025 05.06.2025 |
6 months | +0.93% |
05.12.2024 - 05.06.2025
05.12.2024 05.06.2025 |
1 year | +3.38% |
05.06.2024 - 05.06.2025
05.06.2024 05.06.2025 |
2 years | +7.07% |
26.04.2024 - 05.06.2025
26.04.2024 05.06.2025 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UBS (Lux) ES Enga for Imp(USD) UX Acc | 14.02% | |
---|---|---|
UBS MSCI ACWI Universal ETF USD dis | 8.99% | |
UBS (Lux) ES Glb Opp sust($) U-X acc | 5.55% | |
UBS (Lux) BS Grn Scl Ss Bds (EUR)U-X-acc | 4.79% | |
UBS (Lux) EF Global Imp(USD)U-X-acc | 4.69% | |
Nestle SA | 4.26% | |
UBS (Lux) ES L/T Thms $ USD U-X-acc | 3.79% | |
UBS (Lux) ES Active Clmt Awr USD I-X | 3.69% | |
Novartis AG Registered Shares | 3.63% | |
UBS (Lux) ES Global Hi Div $ I-X-acc | 3.63% | |
Last data update | 30.04.2025 |
TER *** | 1.06% |
---|---|
TER date *** | 31.01.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.88% |
Ongoing Charges *** | 1.05% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |